Reading the market regime before prices move
Reading the market regime before prices move
Every number here is computed from the traded VRTX options chain. The call wall is where dealer hedging accumulates above spot and caps upside, the put wall is its mirror below, and the gamma flip is the level where hedging stops damping moves and starts amplifying them.
Computed
Last completed session, from the Finviro engine close archive · today's session levels refresh every five minutes inside the platform.
Price moves between these levels whether you see them or not. The difference is knowing them before your decision, not after.
You can check SPY, QQQ, NVDA in full right now, with no subscription.
Vertex Pharmaceuticals Incorporated is a company in the Healthcare sector, listed on the NASDAQ Global Select since 1991, with a market value of about $128.61B. It is led by Reshma Kewalramani and has about 6,400 employees.
Vertex Pharmaceuticals Incorporated is a leading biotechnology firm primarily focused on the discovery, advancement, and marketing of innovative treatments, particularly for cystic fibrosis (CF). The company offers a range of approved medications for CF patients, including SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO, which target specific mutations within the cystic fibrosis transmembrane conductance regulator gene.…
Its beta is 0.32: the stock is usually calmer than the broad market, so its moves are narrower than the index.
On the price was $524.52, above its 50-day simple average (DMA-50 at $522.47) by 0.4%, and above its 200-day average (DMA-200 at $476.46) by 10%. Price is above both averages: the medium- and long-term trend is up.
Revenue was $12B in fiscal year 2025, against $7.57B in 2021, a change of +58% over 4 years.
Out of every $100 of revenue, about $33 is left as net income after all costs and taxes, so the net margin is 33%.
The operating margin is 35%: what is left of revenue after operating costs, before interest and taxes.
Earnings per share were $15.46 in 2025, against $9.09 in 2021.
Free cash flow was $3.19B: the cash left after spending on operations and investment, which funds dividends and buybacks.
Debt to equity is 0.37: the higher it is, the more the company relies on borrowing.
These numbers describe the company's size and profitability and change slowly, while gamma levels describe how the stock moves within the session.
